# BlackRock Income and Growth Investment Trust NAV returns +2.2% during November

- Link: https://www.directorstalkinterviews.com/blackrock-income-and-growth-investment-trust-nav-returns-2-2-during-november/4121181660
- Published: 2024-12-20T08:12:32+00:00
- Author: Amilia Stone

**BlackRock Income and Growth Investment Trust plc** ([LON:BRIG](https://www.directorstalkinterviews.com/company/blackrock-income-and-growth-investment-trust-plc/brig.l))
has announced its latest portfolio update.

All information is at **30 November 2024** and unaudited.

**For more information on the BlackRock Income and Growth Investment Trust, please
visit: [www.blackrock.com/uk/brig](https://www.blackrock.com/uk/individual/products/investment-trusts/our-range/blackrock-income-and-growth-investment-trust/trust-information?siteEntryPassthrough=true&cid=aff:investmenttrusts2020:brig:directorstalk:link)**

Performance at month end with net income reinvested

|  | **One****Month** | **Three****Months** | **One****Year** | **Three****Years** | **Five****Years** | **Since****1 April****2012** | 
| **Sterling** |  |  |  |  |  |  | 
| Share price | 0.0% | -5.1% | 10.7% | 16.9% | 19.1% | 130.3% | 
| Net asset value | 2.2% | -1.0% | 14.5% | 26.4% | 30.8% | 142.6% | 
| FTSE All-Share Total Return | 2.5% | -0.5% | 15.7% | 25.5% | 32.2% | 138.1% | 
|   |  |  |  |  |  |  | 
| Source: BlackRock |  |  |  |  |  |  |

BlackRock took over the investment management of the Company with effect from 1 
April 2012.

**At month end**

Sterling:

| Net asset value – capital only: | 221.63p | 
| Net asset value – cum income*: | 226.91p | 
| Share price: | 193.50p | 
| Total assets (including income): | £48.5m | 
| Discount to cum-income NAV: | 14.7% | 
| Gearing: | 2.4% | 
| Net yield**: | 3.9% | 
| Ordinary shares in issue***: | 19,619,612 | 
| Gearing range (as a % of net assets): | 0-20% | 
| Ongoing charges****: | 1.28% | 
| ^( )^(*)^( )Includes net revenue of 5.28 pence per share | 
| ** The Company’s yield based on dividends announced in the last 12 months as at the date of the release of this announcement is 3.9% and includes the 2023 final dividend of 4.80p per share declared on 21 December 2023 with pay date 15 March 2024, and the Interim Dividend of 2.70p per share declared on 20 June 2024 with pay date 29 August 2024. | 
| *** excludes 10,081,532 shares held in treasury. | 
| **** The Company’s ongoing charges are calculated as a percentage of average daily net assets and using management fee and all other operating expenses excluding finance costs, direct transaction costs, custody transaction charges, VAT recovered, taxation and certain non-recurring items for the year ended 31 October 2023.  In addition, the Company’s Manager has also agreed to cap ongoing charges by rebating a portion of the management fee to the extent that the Company’s ongoing charges does not exceed 1.15% of average net assets. |

| **Sector Analysis** | **Total assets (%)** | 
| Support Services |  10.2 | 
| Banks |  10.1 | 
| Media |  8.2 | 
| Pharmaceuticals & Biotechnology |  6.4 | 
| Nonequity Investment Instruments |  6.2 | 
| Real Estate Investment Trusts |  5.9 | 
| Oil & Gas Producers | 5.8 | 
| Mining | 5.4 | 
| General Retailers | 5.3 | 
| Financial ServicesIndustrial Engineering | 5.23.6 | 
| Personal Goods | 3.2 | 
| Travel & LeisureHousehold Goods & Home Construction | 2.82.8 | 
| Nonlife Insurance | 2.5 | 
| Gas, Water & Multiutilities | 2.4 | 
| Tobacco | 2.4 | 
| Food Producers | 2.2 | 
| Electronic & Electrical Equipment | 1.3 | 
| Life Insurance | 1.1 | 
| General Industrials | 0.9 | 
| Net Current Assets | 6.1 | 
|   | —– | 
| Total | 100.0 | 
|   | ===== | 
| **Country Analysis** | **Percentage**  | 
| United Kingdom | 90.2 | 
| United States | 2.2 | 
| Switzerland | 1.5 | 
| Net Current Assets | 6.1 | 
|   | —– | 
|   | 100.0 | 
|    |   | 
| **Top 10 Holdings** | **Fund %** | 
|  AstraZeneca | 5.8 | 
|  RELX | 5.7 | 
|  Shell | 5.2 | 
|  3i Group | 4.4 | 
|  Rio Tinto | 4.1 | 
|  HSBC Holdings | 4.0 | 
|  Unilever | 3.5 | 
|  London Stock Exchange Group | 3.3 | 
|  Standard Chartered | 3.2 | 
|  Pearson | 3.0 | 
|   |   |

**Commenting on the markets, representing the Investment Manager noted:**

**Performance Overview:**

The Company returned +2.2% during the month net of fees, performing in-line with
the FTSE All-Share Index which returned +2.5%.^(1)

**Market Summary:**

Led by the US, equity markets rose in November following the results of the US Presidential
Election. The S&P500 Index rose by 5.7%, logging the best month of 2024 so far as
the post-election optimism lifted markets broadly.

In the UK, the Bank of England reduced interest rates by 25bps, lowering the benchmark
rate from 5% to 4.75%, a move widely anticipated by markets. Meanwhile, the UK’s
Consumer Prices Index revealed inflation rose by 2.3% in the 12-months to October
^(2), driven by a surge in gas and electricity prices as the energy cap went up 
on 1 October.

The FTSE All-Share returned +2.5% in November, whilst the FTSE100 returned +2.6%.
The top-performing sectors during this period were technology, telecommunications,
and financials. Shares in health care companies slid on the announcement of Donald
Trump’s choice of vaccine sceptic, Robert F Kennedy Jr, as US Health Secretary concerned
investors.

**Stock comment**

3i was amongst the strongest positive contributors to the fund during the month 
as continued positive trading from its largest asset, Action, buoyed investor expectations.
The strong like-for-like growth and space rollout continues to offer a highly attractive
return despite the significant rise in the shares over the past 3 years.

Modest contributions were seen from Pearson and Spirax; both of which rose during
the month as investors reassessed their expectations upwards going into 2025. Mastercard
benefited from the rising optimism seen in the US market following the election.
Not owning Glencore and Diageo also modestly contributed as both underperformed.

In terms of detractors, Ashmore fell during the month post the US election as investors
feared that US exceptionalism and a stronger dollar would weigh on emerging market
flows. Similarly, SGS, the Swiss testing business, was weaker as concerns that potential
tariffs would reduce exports and therefore, revenues.

Big Yellow Group disappointed investors during the month with a slightly weaker 
half where disruption caused by concerns around the budget led to weaker than expected
demand.  Although trading has stabilised since, business confidence ahead of the
budget was impacted and decisions were delayed. Sage, which the portfolio does not
own, performed very strongly following a larger than expected buyback and good trading.
As a result of not owning it, this detracted from performance.

**Changes**

We added to positions in Lloyds and Travis Perkins during the month. Lloyds has 
been weak given the concerns on motor finance redress. We believe the strong capital
position at Lloyds allows it flexibility to deal with these issues and continue 
to generate excess free cash flow. We modestly increased the Travis Perkins position
following a good meeting with the new management team. There is unlikely to be a
significant turnaround in the near-term, however, we believe there is an attractive
medium-term opportunity for profitability and cashflow to be rebuilt.

We funded these purchases by reducing the Taylor Wimpey position; managing our exposure
to UK domestic and interest rate sensitives. We also modestly reduced the Hammerson
position for similar reasons as we see greater upside elsewhere.

**Outlook**

Global developed equity markets have continued their broad rallies throughout 2024
following a trend that started in late 2023. Following a lengthy period of uncertainty
through the COVID-19 era, with sharply rising interest rates and inflation, equity
markets have now settled down. Having passed peak interest rates, and with stable
labour markets and broadly stable macroeconomic conditions, equity markets have 
moved to goldilocks territory. The promise of greater fiscal spending in the US,
China and parts of Europe have served to buoy equity markets further, although have
contributed to rising government bond yields as the spectre of fiscal deficits and
inflationary pressures loom large for bond investors.

More recently, following a period of extended economic weakness, the Chinese Government
begun a more concerted accommodative campaign aimed at accelerating economic growth
and arresting deflationary pressures. Recent policy moves have sought to improve
and encourage lending into the real economy with a sizable fiscal easing programme
announced. Whilst the scale of the easing is large, western markets and commentators
have remained sceptical of its impact and effectiveness whilst awaiting evidence
to the contrary. In the UK, the recent budget promised and delivered a large-scale
borrowing and spending plan whilst sizable increases in minimum wage and public 
sector wage agreements likely support a brighter picture for the UK consumer. UK
labour markets remain resilient for now with low levels of unemployment while real
wage growth is supportive of consumer demand albeit presents a challenge to corporate
profit margins.

With the UK’s election and budget now over, the market’s attention will focus on
the subsequent policy actions of the new US administration under Donald Trump. The
global economy has benefited from significant growth and deflation `dividend’ it
has received from globalisation over the past decades. The impact of a more protectionist
US approach and the potential implementation of tariffs may challenge this dividend.
We would anticipate asset markets to be wary of these policies until there is more
clarity as we move through 2025. Conversely, we believe political certainty, now
evident in the UK, will be helpful for the UK and address the UK’s elevated risk
premium that has persisted since the damaging Autumn budget of 2022. Whilst we do
not position the portfolios for any election or geopolitical outcome, we are mindful
of the potential volatility and the opportunities that may result, some of which
have started to emerge.

The UK stock market continues to remain depressed in valuation terms relative to
other developed markets offering double-digit discounts across a range of valuation
metrics. This valuation anomaly saw further reactions from UK corporates with a 
robust buyback yield of the UK market. Combining this with a dividend yield of 3.7%(
FTSE All Share Index yield as at 31 October 2024; source: The Investment Association),
the cash return of the UK market is attractive in absolute terms and comfortably
higher than other developed markets. Although we anticipate further volatility ahead,
we believe that in the course of time risk appetite will return and opportunities
are emerging. We have identified several potential opportunities with new positions
initiated throughout the year in both UK domestic and midcap companies.

We continue to focus the portfolio on cash generative businesses that we believe
offer durable, competitive advantages as we believe these companies are best placed
to drive returns over the long term. Whilst we anticipate economic and market volatility
will persist throughout the year, we are excited by the opportunities this will 
likely create; by seeking to identify the companies that strengthen their long-term
prospects as well as attractive turnaround situations.

^(1)Source: BlackRock

^(2)Source: Office of National Statistics

https://www.ons.gov.uk/economy/inflationandpriceindices/bulletins/consumerpriceinflation/
october2024#:~:text=in%20October%202023.-,The%20Consumer%20Prices%20Index%20(CPI)%
20rose%20by%202.3%25%20in,of%2011.1%25%20in%20October%202022.

**For more information on the BlackRock Income and Growth Investment Trust, please
visit: [www.blackrock.com/uk/brig](https://www.blackrock.com/uk/individual/products/investment-trusts/our-range/blackrock-income-and-growth-investment-trust/trust-information?siteEntryPassthrough=true&cid=aff:investmenttrusts2020:brig:directorstalk:link)**

Share on:
